Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases
05 janv. 2017 10h05 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that it has entered into an agreement with InnVentis Ltd. to apply...
Metabolon Raises Additional $15 Million in Funding From Essex Woodlands
05 déc. 2016 10h52 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding from...
Metabolon Launches Meta IMD™ Test to Speed Diagnosis of Inherited Metabolic Disorders
28 sept. 2016 10h05 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that Meta IMD™ is now available to physicians as a CLIA...
Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities
11 août 2016 10h10 HE
|
Metabolon, Inc.
Financing Adds Essex Woodlands as New Investor Scott Barry to Join Metabolon’s Board of Directors RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global...
Metabolon to Develop accuGFR™ Kidney Function Test With Johns Hopkins and Tufts Medical Center
02 juin 2016 16h00 HE
|
Metabolon, Inc.
More accurate kidney function test needed for chronic kidney disease“Silent killer” can go undetected without symptoms until patient has lost 90 percent of kidney function RESEARCH TRIANGLE PARK,...
Metabolon Identifies Biomarkers with Superior Diagnostic Performance Over Creatinine for Chronic Kidney Disease
28 avr. 2016 15h50 HE
|
Metabolon, Inc.
Data presented at National Kidney Foundation 2016 Spring Clinical MeetingsMetabolites form basis of accuGFR™ test in development RESEARCH TRIANGLE PARK, N.C., April 28, 2016 (GLOBE NEWSWIRE) --...
Metabolon and SYNLAB Group Form Commercialization Collaboration for Quantose™ IR Diagnostic
29 mars 2016 09h59 HE
|
Metabolon, Inc.
SYNLAB Group to market Quantose IR, a laboratory-developed test used to identify insulin resistanceInitial launch in SpainAdditional markets to follow in 2016 RESEARCH TRIANGLE PARK, N.C., March 29,...
Lisa Miller Joins Metabolon as VP of Precision Medicine
07 déc. 2015 16h15 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces that Lisa A. Miller has been appointed Vice President and General...
Metabolon and Baylor College of Medicine Show Metabolomics May Play Key Role in Precision Medicine
17 août 2015 17h34 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, today announced study results indicating that its technology is emerging as an...
Darin Leigh Joins Metabolon as Chief Commercial Officer
06 juil. 2015 11h18 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., July 6, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces that Darin Leigh has been appointed Chief Commercial Officer, a new...